Do not self-inject
OXONEG 600MG INJECTION is not recommended for use in pregnant and breastfeeding women unless it is clearly necessary
When I discuss GHK-Cu for hair loss in perimenopause, I am honest about this: the mechanism is real, the safety profile is excellent, the early human signals are promising, but the head-to-head trial evidence is not where it needs to be
He, L., Diedrich, J., Chu, Y
Research shows Ipamorelin promotes growth pathways without significant fluctuations in other hormones by selectively stimulating growth hormone release making it a compound of interest in peptide research
Trust Your Instincts: If something seems off about a product or supplier, it's better to err on the side of caution